Effectiveness and Clinical Outcomes of Long-term Bulevirtide Monotherapy in Patients With HDV-related Compensated Cirrhosis

NCT06397859 · clinicaltrials.gov ↗

RECRUITING

Status

266

Enrollment

OTHER

Sponsor class

Conditions

Hepatitis D

Interventions

DRUG: Bulevirtide

Sponsor

Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico